Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bram Rochwerg

Showing results (1-10 of 479) with videos related to

Pageof 48
Sort By:
Canadian Journal of Anaesthesia = Journal Canadien D'Anesthesie|January 5, 2019
Providing expert guidance in the evidence-based medicine era?Bram Rochwerg
Intensive Care Medicine|May 13, 2022
Corticosteroids for severe community-acquired pneumonia: a story without an endingBram Rochwerg
Critical Care Medicine|October 30, 2025
End-of-Life Care in the ICU: Getting Good Recommendations From Bad EvidenceJames Downar, Bram Rochwerg
American Journal of Respiratory and Critical Care Medicine|January 14, 2017
Reply: Can Bisphosphonates Prevent Vitamin K Antagonist Toxicity in Patients with Idiopathic Pulmonary Fibrosis?Ganesh Raghu, Bram Rochwerg
Annals of Internal Medicine|February 1, 2021
Tocilizumab did not reduce hypoxemic respiratory failure or death in hospitalized patients with COVID-19Sameer Sharif, Bram Rochwerg
Critical Care Medicine|November 17, 2022
The authors replySameer Sharif, Bram Rochwerg
American Journal of Respiratory and Critical Care Medicine|April 2, 2016
Reply: Can Warfarin Be Used in the Treatment of Pulmonary Embolism in Idiopathic Pulmonary Fibrosis?Bram Rochwerg, Ganesh Raghu
Journal of Intensive Medicine|September 23, 2024
Adaptive platform trials in critical careMuralie Vignarajah, Bram Rochwerg
Annals of Internal Medicine|October 3, 2022
In adults hospitalized with COVID-19, adding baricitinib vs. dexamethasone to remdesivir did not differ for MV-free survivalAlexandre Tran, Bram Rochwerg
Annals of Internal Medicine|January 31, 2022
In COVID-19, escalated- vs. prophylactic-dose anticoagulation does not reduce mortality and increases major bleedingDipayan Chaudhuri, Bram Rochwerg
Pageof 48

Showing results (1-10 of 479) with videos related to

Sort By:
Pageof 48
Canadian Journal of Anaesthesia = Journal Canadien D'Anesthesie|January 5, 2019
Providing expert guidance in the evidence-based medicine era?Bram Rochwerg
Intensive Care Medicine|May 13, 2022
Corticosteroids for severe community-acquired pneumonia: a story without an endingBram Rochwerg
Critical Care Medicine|October 30, 2025
End-of-Life Care in the ICU: Getting Good Recommendations From Bad EvidenceJames Downar, Bram Rochwerg
American Journal of Respiratory and Critical Care Medicine|January 14, 2017
Reply: Can Bisphosphonates Prevent Vitamin K Antagonist Toxicity in Patients with Idiopathic Pulmonary Fibrosis?Ganesh Raghu, Bram Rochwerg
Annals of Internal Medicine|February 1, 2021
Tocilizumab did not reduce hypoxemic respiratory failure or death in hospitalized patients with COVID-19Sameer Sharif, Bram Rochwerg
Critical Care Medicine|November 17, 2022
The authors replySameer Sharif, Bram Rochwerg
American Journal of Respiratory and Critical Care Medicine|April 2, 2016
Reply: Can Warfarin Be Used in the Treatment of Pulmonary Embolism in Idiopathic Pulmonary Fibrosis?Bram Rochwerg, Ganesh Raghu
Journal of Intensive Medicine|September 23, 2024
Adaptive platform trials in critical careMuralie Vignarajah, Bram Rochwerg
Annals of Internal Medicine|October 3, 2022
In adults hospitalized with COVID-19, adding baricitinib vs. dexamethasone to remdesivir did not differ for MV-free survivalAlexandre Tran, Bram Rochwerg
Annals of Internal Medicine|January 31, 2022
In COVID-19, escalated- vs. prophylactic-dose anticoagulation does not reduce mortality and increases major bleedingDipayan Chaudhuri, Bram Rochwerg
Pageof 48